Freestone Grove Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$100M Buy
+1,183,835
New +$95.5M 0.64% 26
2025
Q2
Sell
-600,966
Closed -$48.3M 787
2025
Q1
$48.3M Buy
600,966
+441,952
+278% +$36.8M 0.5% 64
2024
Q4
$13M Buy
+159,014
New +$13.2M 0.16% 177

Other funds holding MET

Freestone Grove Partners's MET Position: Q2 2026 in Review

Freestone Grove Partners opened a new position in MetLife (MET) in Q2 2026: 1,183,835 shares worth $100M. The stake represents 0.64% of the portfolio and ranks #26 among its holdings. This is a return to the name: Freestone Grove Partners previously reported a position in MET as recently as Q1 2025.

Freestone Grove Partners first reported a position in MET in Q4 2024 and has held it in 3 quarters since. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Freestone Grove Partners held 1,183,835 shares of MetLife worth $100M as of Q2 2026.
  • MetLife was a new Freestone Grove Partners position in Q2 2026.
  • MetLife made up 0.64% of Freestone Grove Partners's portfolio in Q2 2026, its #26 holding.
  • Freestone Grove Partners first reported a position in MetLife in Q4 2024 and has held it in 3 quarters since.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.